Elevated CLDN4 expression in glioma tissues are associated with poor clinical outcomes, and Yang et al. further demonstrated a positive correlation between CLDN4 expression and the more advanced clinical stages of glioma patients, what was assessed using immunohistochemical staining (IHC) (38). Here, CLDN4 is linked to glioma.